BioCentury
ARTICLE | Clinical News

Fluoratec: Began Phase I/II testing

May 22, 2000 7:00 AM UTC

Boston Life Sciences Inc. (BLSI), Boston, Mass. Product: Fluoratec Business: Diagnostics/Imaging, Neurological Therapeutic category: Test Target: Dopamine transporters in the brain Description: Techne...